cerrar
Tagged with UK

Pfizer’s Nordkamp Takes ABPI Presidency
Erik Nordkamp, managing director of Pfizer UK, has been confirmed as the new president of the Association of the British Pharmaceutical Industry…

Interview: Craig Wallace – General Manager UK and Ireland,…
Craig Wallace established the UK affiliate of Santen, the Japanese ophthalmology company, in 2014. Wallace describes the journey Santen has been on so…

A Critical Juncture for the UK’s Vaccines Industry
Britain, home of the discovery of the world’s first ever vaccine, has long been championing a pharma sub-segment forecast to reach a global market…

Interview: Thomas Bo Bjorn Klee – Managing Director,…
Thomas Bo Bjorn Klee, managing director of Lundbeck UK and Ireland, describes the global restructuring program Lundbeck initiated two years ago to…

Interview: Andrew Hotchkiss – CEO, Immunocore, UK
Having recently been able to present positive data for their lead technology IMCgp100 in uveal melanoma at the American Society of Clinical Oncology…

Erik Nordkamp – Managing Director, Pfizer UK
Erik Nordkamp, managing director of Pfizer UK shares his thoughts on the future of healthcare and the role that Pfizer and the UK can play in shaping…

Interview: Stewart Pearce – Managing Director, Otsuka UK…
Stewart Pearce, managing director of Otsuka UK and Ireland since 2017 discloses how he built up a leadership team fit for the Otsuka of 2023 and…

Brexit: A Serious Threat to Patients
As the UK extracts itself from the European Union, key figures from the country's life sciences sector are split on the implications of Brexit for…

Interview: Nelson Pires – General Manager, Jaba Recordati…
Nelson Pires provides an insightful update on Portugual’s pharmaceutical market evolution as well as Jaba Recordati’s ambitious Portuguese…

Interview: Chris Molloy – Chief Executive, Medicines…
Chris Molloy, chief executive of the Medicines Discovery Catapult (MDC), discusses its role within the UK as a center for applied medical R&D and…

Interview: Gary Hendler – Chairman & CEO, Eisai EMEA
Confirming Eisai’s commitment to keeping its EMEA headquarters in the UK, Gary Hendler, chairman and CEO EMEA, and Nick Burgin, COO and president of…

Top Pharma R&D Spenders in Europe Ranking
The top spenders on pharma R&D in Europe for 2015 were Switzerland - which spent over EUR 6.5 billion - followed by Germany - which spent EUR 6.2…
We use cookies to ensure that we give you the best experience on our site. For more info

See our Cookie Privacy Policy Here